U.S. pharma large copyright scrapped two experimental weight loss supplements past yr—a once-day-to-day capsule, lotiglipron, as a result of elevated liver enzymes as well as a two times-daily capsule, danuglipron, because of powerful Unwanted effects—but CEO Albert Bourla has said t